Dr. Salehizadeh is a cofounder of NaviMed and has over 20 years of healthcare operating and investment experience. He sits on the NaviMed Investment Committee and is responsible for leading investments and overseeing portfolio companies with a particular focus on healthcare providers and pharmaceutical services. He holds an AB in Molecular Biology from Princeton University, an MD and MS in Health Policy from Columbia University, and an MBA from Harvard Business School. He is also a graduate of the Kauffman Fellows Program.